MarketGrader Health Care Index


Five Largest Companies (Top 5 of 19)
Symbol Name Grade Market Cap Country
JNJ Johnson & Johnson 63.8 $465,600.00 US
PFE Pfizer Inc. 86.9 $284,248.00 US
ABBV AbbVie, Inc. 64.4 $269,467.00 US
DHR Danaher Corporation 62.7 $183,136.00 US
ZTS Zoetis, Inc. Class A 56.9 $80,063.40 US

Five Smallest Companies (Top 5 of 1)
Symbol Name Grade Market Cap Country
CODX Co-Diagnostics, Inc. 80.2 $173.00 US
SMLR Semler Scientific, Inc. 62.4 $198.15 US
IRMD IRadimed Corp. 65.9 $423.55 US
CARA Cara Therapeutics Inc 28.3 $496.26 US
ORGO Organogenesis Holdings, Inc. Class A 72.3 $612.08 US

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
WAT Waters Corporation 69.2 37 US
JNJ Johnson & Johnson 63.8 36 US
REGN Regeneron Pharmaceuticals, Inc. 80.2 32 US
GMED Globus Medical Inc Class A 49.2 26 US
VIVO Meridian Bioscience, Inc. 72.1 25 US
CHE Chemed Corporation 58.8 23 US
INVA Innoviva, Inc. 69.5 22 US
COO Cooper Companies, Inc. 49.5 21 US
CORT Corcept Therapeutics Incorporated. 71.0 18 US
ABBV AbbVie, Inc. 64.4 18 US
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap $45,283.64
Median Market Cap $7,012.46
Avg. 3 Mo. Dollar Vol. $216,677,695.83
Avg. 3 Mo. Trading Vol. 1,940,995
Last Rebalance Date 02/22/2022
Companies Replaced 10
Biggest Industry Increase Pharmaceuticals: Major
Biggest Industry Decrease Medical Specialties
Companies Overlapping S&P 500 18

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 18.0
Forward P/E Ratio (12 Mo.) 21.38
Price/Book Ratio 3.51
Avg. Revenue Chg. - 3 Yr 53.2%
Avg. Op. Income Chg. - 3 Yr. 122.01%
Avg. EPS Growth - 3 Yr. 30.12%
Avg. EPS Growth - 1 Yr. 23.37%
Avg. Operating Margin 26.45%
Avg. LT Debt to Total Capital 18.22%
Avg. Return on Equity 28.22%
Dividend Yield 0.0%
Index Average Grade
MarketGrader Health Care Index 67.47
Country Breakdown
United States Of America 95.0%


For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE